OnKure Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell OKUR and other ETFs, options, and stocks.

About OKUR

OnKure Therapeutics, Inc. engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure and computational chemistry driven drug design platform, committed to improving clinical outcomes for patients by building a robust pipeline of small molecule drugs designed to selectively target specific mutations thought to be key drivers of cancer. 

CEO
Nicholas A. Saccomano
CEONicholas A. Saccomano
Employees
46
Employees46
Headquarters
Boulder, Colorado
HeadquartersBoulder, Colorado
Founded
Founded
Employees
46
Employees46

OKUR Key Statistics

Market cap
24.86M
Market cap24.86M
Price-Earnings ratio
-0.32
Price-Earnings ratio-0.32
Dividend yield
Dividend yield
Average volume
154.34K
Average volume154.34K
High today
$2.11
High today$2.11
Low today
$1.70
Low today$1.70
Open price
$1.99
Open price$1.99
Volume
758.65K
Volume758.65K
52 Week high
$20.00
52 Week high$20.00
52 Week low
$1.70
52 Week low$1.70

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own OKUR. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.